Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 13, 2026
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage populationDanielle Beaulieu, Kelly Smith, Campbell Ross, et al.Cancer|December 31, 2009
Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomaMichael R Bishop, Robert M Dean, Seth M Steinberg, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2005
Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphomaRobert M Dean, Daniel H Fowler, Wyndham H Wilson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantationNancy M Hardy, Frances Hakim, Seth M Steinberg, et al.EMBO Molecular Medicine|March 17, 2022
Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disordersMurtaza S Nagree, Tania C Felizardo, Mary L Faber, et al.Transfusion|October 27, 2018
Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independenceLinda M Griffith, Mark VanRaden, A John Barrett, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2Miriam E Mossoba, Jagdeep S Walia, Vanessa I Rasaiah, et al.Cytotherapy|January 29, 2013
Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cellsLuciano Castiello, Miriam Mossoba, Antonella Viterbo, et al.Journal for Immunotherapy of Cancer|January 28, 2025
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myelomaBinod Dhakal, Parameswaran Hari, Saurabh Chhabra, et al.Science Translational Medicine|October 25, 2013
Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppressionRaffit Hassan, Andrew C Miller, Elad Sharon, et al.Pageof 12